Home/Geneoscopy/Andrew Barnell

AB

Andrew Barnell

Co-Founder & CEO

Therapeutic Areas

Gastrointestinal Diseases Colorectal Cancer Inflammatory Bowel Disease

Geneoscopy Pipeline

Drug	Indication	Phase
ColoSense	Colorectal Cancer Screening	Approved
seRNA Platform for IBD	Inflammatory Bowel Disease (Ulcerative Colitis, Crohn's) Diagnosis/Monitoring	Pre-clinical

Leadership Team at Geneoscopy

Dr. Erica Barnell

Co-Founder & Chief Science Officer

View full Geneoscopy profile